Your browser doesn't support javascript.
Primary angiosarcoma of breast: A case report and literature review.
Li, Min; Yin, Ke; Chen, Lin; Shang, Xingchen; Yang, Qing; Tian, Xingsong.
  • Li M; Department of Breast and Thyroid Surgery, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China. Electronic address: 202136022@mail.sdu.edu.cn.
  • Yin K; Department of Pathology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China.
  • Chen L; Department of Breast and Thyroid Surgery, The Second Hospital of Shandong University, Shandong University, Jinan, Shandong, China.
  • Shang X; Department of Breast and Thyroid Surgery, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China.
  • Yang Q; Department of Breast and Thyroid Surgery, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China.
  • Tian X; Department of Breast and Thyroid Surgery, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China. Electronic address: txs0509@163.com.
Int J Surg Case Rep ; 106: 108219, 2023 May.
Article in English | MEDLINE | ID: covidwho-2316535
ABSTRACT
INTRODUCTION AND IMPORTANCE Primary angiosarcoma of breast (PAB)3 is a rare and aggressive malignancy with limited published literature. This article aims to disclose the diagnosis and treatment of this case, review previous case reports, and provide clinical experience to breast surgeons. CASE PRESENTATION A 36-year-old Asian female presented with a diffuse mass growing rapidly in her left breast. The ultrasonography (USG)4 suspected granulomatous mastitis. The core needle biopsy (CNB)5 confirmed the diagnosis of breast angiosarcoma (AS).6 She underwent mastectomy without axillary lymph node dissection (ALND)7 followed by adjuvant chemotherapy. About 11 months after mastectomy, the patient had bone metastasis. CLINICAL

DISCUSSION:

PAB is a rare vascular neoplasia, characterized by aggressive patterns, poor prognosis, and high malignant potential. It is difficult to diagnose or differentiate only by clinical or imaging examination. Biopsy and immunohistochemical staining are the most reliable method. Mastectomy is the most common treatment.

CONCLUSION:

PAB is a rare and malignant cancer. We should pay attention to the diffuse progressive masses in the breast of young female, and perform MRI and biopsy if necessary. Mastectomy is the only treatment known that has proven to benefit these patients. There are no evidence-based guidelines regarding treatment.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study / Reviews Language: English Journal: Int J Surg Case Rep Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study / Reviews Language: English Journal: Int J Surg Case Rep Year: 2023 Document Type: Article